Graft Survival

• 

  Subject Areas on Research

  • 'Chimeric' grafts assembled from multiple allodisparate donors enjoy enhanced transplant survival. 
  • A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis. 
  • A GPS for finding the route to transplantation for the sensitized patient. 
  • A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft. 
  • A Propensity-matched Survival Analysis: Do Simultaneous Liver-lung Transplant Recipients Need a Liver? 
  • A comparison of alemtuzumab with basiliximab induction in simultaneous pancreas-kidney transplantation. 
  • A comparison of donor-specific and random transfusions in living-related renal transplantation and their effect on steroid withdrawal. 
  • A comparison of murine T-cell-depleted adult bone marrow and full-term fetal blood cells in hematopoietic engraftment and immune reconstitution. 
  • A controlled, double-blind, randomized trial of verapamil and cyclosporine in cadaver renal transplant patients. 
  • A cyclosporine-based immunosuppressive regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C. 
  • A literature review and meta-analysis of outcomes in microsurgical reconstruction using vasopressors. 
  • A long-term experience with expansion of Milan criteria for liver transplant recipients. 
  • A meta-analysis of complications following deceased donor liver transplant. 
  • A model of sequential heart and composite tissue allotransplant in rats. 
  • A new rat infection-heart transplant model: effect of infection on graft survival studies. 
  • A novel immune competent murine hypertrophic scar contracture model: a tool to elucidate disease mechanism and develop new therapies. 
  • A novel monoclonal antibody to CD40 prolongs islet allograft survival. 
  • A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases. 
  • A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action. 
  • A prospective randomized trial of OKT3 vs ATGAM induction therapy in pancreas transplant recipients. 
  • A randomized study comparing leukocyte-depleted versus packed red cell transfusions in prospective cadaver renal allograft recipients. 
  • A reduced-toxicity regimen is associated with durable engraftment and clinical cure of nonmalignant genetic diseases among children undergoing blood and marrow transplantation with an HLA-matched related donor. 
  • A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. 
  • A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation. 
  • A synergistic effect of total lymphoid irradiation, cyclosporine, and splenectomy in a hamster-to-rat hepatic xenograft model. 
  • ACR Appropriateness Criteria® Renal Transplant Dysfunction. 
  • APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors. 
  • APOL1: a case in point for replacing race with genetics. 
  • Absence of donor MHC antigen expression ameliorates chronic kidney allograft rejection. 
  • Absence of hyperacute rejection in newborn pig-to-baboon cardiac xenografts. 
  • Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival. 
  • Acute difluoromethylornithine treatment increases skin flap survival in rats. 
  • Addition of a second, different allogeneic graft accelerates white cell and platelet engraftment after T-cell-depleted bone marrow transplantation. 
  • Addition of interleukin-6 receptor blockade to carfilzomib-based desensitization in a highly sensitized nonhuman primate model. 
  • Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens. 
  • Advances in pancreas transplantation: the University of Wisconsin experience. 
  • Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years. 
  • Aggressive pursuit and utilization of non-ideal donor lungs does not compromise post-lung transplant survival. 
  • Air bubble-associated endothelial trauma in descemet stripping automated endothelial keratoplasty. 
  • Albuminuria and Allograft Failure, Cardiovascular Disease Events, and All-Cause Death in Stable Kidney Transplant Recipients: A Cohort Analysis of the FAVORIT Trial. 
  • Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates. 
  • Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation. 
  • Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death. 
  • Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors. 
  • Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency. 
  • Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita. 
  • Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors. 
  • Allograft anterior cruciate ligament reconstruction in a sheep model. The effect of synthetic augmentation. 
  • Alternative immunomodulatory strategies for xenotransplantation: CD40/154 pathway-sparing regimens promote xenograft survival. 
  • An appraisal of technical variant grafts compared to whole liver grafts in pediatric liver transplant recipients: Multicenter analysis from the SPLIT registry. 
  • Analysis of failures after vascularized fibular grafting in femoral head necrosis. 
  • Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9. 
  • Analysis of recurrence, complications, and functional results with free jejunal flaps. 
  • Analysis of tumor characteristics and survival in liver transplant recipients with incidentally diagnosed hepatocellular carcinoma. 
  • Angiotensin II Type 1 receptor antibodies are associated with inflammatory cytokines and poor clinical outcomes in pediatric kidney transplantation. 
  • Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies. 
  • Anti-Leukocyte Function-Associated Antigen 1 Therapy in a Nonhuman Primate Renal Transplant Model of Costimulation Blockade-Resistant Rejection. 
  • Anti-thymoglobulin induction improves neonatal porcine xenoislet engraftment and survival. 
  • Antibody depletion strategy for the treatment of suspected antibody-mediated rejection in lung transplant recipients: Does it work? 
  • Antigen-specific induced Foxp3+ regulatory T cells are generated following CD40/CD154 blockade. 
  • Antioxidant lazaroid U-74006F improves renal function and reduces the expression of cytokines, inducible nitric oxide synthase, and MHC antigens in a syngeneic renal transplant model. Partial support for the response-to-injury hypothesis. 
  • Antireflux surgery in the setting of lung transplantation: strategies for treating gastroesophageal reflux disease in a high-risk population. 
  • Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method. 
  • Application of a Novel CT-Based Iliac Artery Calcification Scoring System for Predicting Renal Transplant Outcomes. 
  • Applying the Keystone Design Perforator Island Flap Concept in a Variety of Anatomic Locations: A Review of 60 Consecutive Cases by a Single Surgeon. 
  • Arterial reconstruction for radial artery occlusion. 
  • Assessment of Heart Transplant Waitlist Time and Pre- and Post-transplant Failure: A Mixed Methods Approach. 
  • Attitudes toward biological mesh in breast reconstruction: a regional survey of plastic surgeons. 
  • Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. 
  • Autologous bone marrow transplantation for acute lymphoblastic leukemia. 
  • Autologous stem cell transplantation for autoimmune diseases: issues in protocol development. 
  • B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment? 
  • Basic fibroblast growth factor expression following surgical delay of rat transverse rectus abdominis myocutaneous flaps. 
  • Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function. 
  • Belatacept and sirolimus prolong nonhuman primate islet allograft survival: adverse consequences of concomitant alefacept therapy. 
  • Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion. 
  • Beneficial effect of plasmapheresis and intravenous immunoglobulin on renal allograft survival of patients with acute humoral rejection. 
  • Beta-adrenergic receptor polymorphisms and cardiac graft function in potential organ donors. 
  • Beyond death and graft survival-Variation in outcomes after liver transplant. Results from the NSQIP transplant beta phase. 
  • Biliary reconstructive techniques and associated anatomic variants in adult living donor liver transplantations: The adult-to-adult living donor liver transplantation cohort study experience. 
  • Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials. 
  • Biomarkers for kidney transplant rejection. 
  • Blocking CCL8-CCR8-Mediated Early Allograft Inflammation Improves Kidney Transplant Function. 
  • Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experience. 
  • Bone marrow-derived AXL tyrosine kinase promotes mitogenic crosstalk and cardiac allograft vasculopathy. 
  • Bosentan, an endothelin antagonist, augments hepatic graft function by reducing graft circulatory impairment following ischemia/reperfusion injury. 
  • Brain death significantly reduces isolated pancreatic islet yields and functionality in vitro and in vivo after transplantation in rats. 
  • Brequinar sodium potentiates the effects of cyclosporine in experimental small bowel transplantation. 
  • Burden of early hospitalization after simultaneous liver-kidney transplantation: Results from the US Multicenter SLKT Consortium. 
  • Busulfan/melphalan/antithymocyte globulin followed by unrelated donor cord blood transplantation for treatment of infant leukemia and leukemia in young children: the Cord Blood Transplantation study (COBLT) experience. 
  • C3 complement inhibition prevents antibody-mediated rejection and prolongs renal allograft survival in sensitized non-human primates. 
  • CD20-positive infiltrates in renal allograft biopsies with acute cellular rejection are not associated with worse graft survival. 
  • CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation. 
  • CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates. 
  • CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection. 
  • CD68/CD31 immunohistochemistry double stain demonstrates increased accuracy in diagnosing pathologic antibody-mediated rejection in cardiac transplant patients. 
  • CTLA4Ig prevents alloantibody formation following nonhuman primate islet transplantation using the CD40-specific antibody 3A8. 
  • Cadaver renal transplantation ignoring peak-reactive sera in patients with markedly decreasing pretransplant sensitization. 
  • Calcineurin inhibitor withdrawal after renal transplantation with alemtuzumab: clinical outcomes and effect on T-regulatory cells. 
  • Campath-1H in renal transplantation: The University of Wisconsin experience. 
  • Campath-1H use in pediatric renal transplantation. 
  • Captopril reduces graft coronary artery disease in a rat heterotopic transplant model. 
  • Cardiac allograft vasculopathy: A review. 
  • Cardiovascular mechanism of donor brain death and heart recipient survival. 
  • Cellular Therapies in Solid Organ Allotransplantation: Promise and Pitfalls. 
  • Cellular and molecular targeting for nanotherapeutics in transplantation tolerance. 
  • Cellular immunology markers postransplantation predictive of long-term graft outcome. 
  • Center-level Variation in HLA-incompatible Living Donor Kidney Transplantation Outcomes. 
  • Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies. 
  • Changes in health-related quality of life in off-pump versus on-pump cardiac surgery: Veterans Affairs Randomized On/Off Bypass trial. 
  • Changing spectrum of pediatric renal transplantation. 
  • Characterization of T cells expressing the gamma/delta antigen receptor in human renal allografts. 
  • Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. 
  • Chronic aspiration of gastric fluid induces the development of obliterative bronchiolitis in rat lung transplants. 
  • Circulating donor antigen and response to donor antigen as predictors of long-term lung and kidney transplant success. 
  • Circulating mitochondria in deceased organ donors are associated with immune activation and early allograft dysfunction. 
  • Class II alloantibody and mortality in simultaneous liver-kidney transplantation. 
  • Clinical Outcomes of Older Kidney Transplant Recipients. 
  • Clinical outcome of interval cadaveric renal transplantation in cardiac allograft recipients. 
  • Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin. 
  • Clinical pancreas preservation and transplantation. 
  • Clinical tolerance 2008. 
  • Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies. 
  • Coagulopathy in α-galactosyl transferase knockout pulmonary xenotransplants. 
  • Combination anti-CD2 and anti-CD3 monoclonal antibodies induce tolerance while altering interleukin-2, interleukin-4, tumor necrosis factor, and transforming growth factor-beta production. 
  • Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation. 
  • Combined liver-kidney and liver transplantation in patients with renal failure outcomes in the MELD era. 
  • Combined total lymphoid irradiation and cyclosporine promote xenograft survival. 
  • Comparison of Laser Doppler and Laser-Assisted Indocyanine Green Angiography Prediction of Flap Survival in a Novel Modification of the McFarlane Flap. 
  • Comparison of Minnesota antilymphoblast globulin and Upjohn antithymocyte globulin for induction immunosuppression of human renal allografts. 
  • Comparison of PRA-STAT, sHLA-EIA, and anti-human globulin-panel reactive antibody to identify alloreactivity in pretransplantation sera of heart transplant recipients: correlation to rejection and posttransplantation coronary artery disease. 
  • Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. 
  • Comparison of guided bone formation from periosteum and muscle fascia. 
  • Comparison of in vivo efficacy and mechanism of action of antimurine monoclonal antibodies directed against TCR alpha beta (H57-597) and CD3 (145-2C11). 
  • Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis. 
  • Complement-targeted therapies in kidney transplantation-insights from preclinical studies. 
  • Composite tissue allotransplantation: past, present and future-the history and expanding applications of CTA as a new frontier in transplantation. 
  • Continuous complement (C) inhibition using soluble C receptor type 1 (sCR1): effect on hyperacute rejection (HAR) of pig-to-primate cardiac xenografts. 
  • Conversion from mycophenolate mofetil to azathioprine in renal allograft [corrected] patients within the first month posttransplantation. 
  • Cord-blood transplants from unrelated donors in Hurler's syndrome. 
  • Corticosteroids and methotrexate as adjuvants to costimulation blockade in non-human primate renal transplantation. 
  • Cost of achieving equivalent outcomes in sicker patients after liver transplant. 
  • Costimulation Blockade Resistant Rejection. 
  • Costimulation Blockade in Vascularized Composite Allotransplantation. 
  • Crosstalk Between T and B Cells in the Germinal Center After Transplantation. 
  • Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplant. 
  • Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT. 
  • Current and future preparative regimens for bone marrow transplantation in thalassemia. 
  • Current challenges and opportunities in the management of antibody-mediated rejection in lung transplantation. 
  • Current concepts and controversies in lung transplantation. 
  • Cutaneous Burn Injury Promotes Shifts in the Bacterial Microbiome in Autologous Donor Skin: Implications for Skin Grafting Outcomes. 
  • Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial. 
  • Cytokine gene polymorphisms are not associated with bronchiolitis obliterans syndrome or survival after lung transplant. 
  • Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28. 
  • DEK regulates hematopoietic stem engraftment and progenitor cell proliferation. 
  • De Novo Visceral Malignancies in Renal Transplant Recipients: A Single Center Experience of 2054 Recipients for More Than 30 Years. 
  • De novo belatacept in clinical vascularized composite allotransplantation. 
  • Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation. 
  • Declining influence of race on the outcome of living-donor renal transplantation. 
  • Decreased graft loss following implementation of the kidney allocation score (KAS). 
  • Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors. 
  • Defining long-term outcomes with living donor liver transplantation in North America. 
  • Definition and Analysis of Textbook Outcome: A Novel Quality Measure in Kidney Transplantation. 
  • Delayed autotransplantation of a solitary kidney facilitated by pump perfusion preservation. 
  • Delayed graft function and acute rejection following HLA-incompatible living donor kidney transplantation. 
  • Depletion of passenger leukocytes from corneal grafts: an effective means of promoting transplant survival? 
  • Depletion of pulmonary intravascular macrophages prevents hyperacute pulmonary xenograft dysfunction. 
  • Descemet's stripping automated endothelial keratoplasty in a patient with four glaucoma tubes. 
  • Design and Implementation of the International Genetics and Translational Research in Transplantation Network. 
  • Determinants of graft survival after renal transplantation. 
  • Determination of the functional status of alloreactive T cells by interferon-gamma kinetics. 
  • Development and future deployment of a 5 years allograft survival model for kidney transplantation. 
  • Development of a protocol for allogeneic marrow transplantation for severe systemic sclerosis: paradigm for autoimmune disease. 
  • Diagnosis and outcome of early pleural space infection following lung transplantation. 
  • Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis. 
  • Differential Role of B Cells and IL-17 Versus IFN-γ During Early and Late Rejection of Pig Islet Xenografts in Mice. 
  • Differential mechanisms of failure of autogenous and non-autogenous bypass conduits: an assessment following successful graft thrombolysis. 
  • Differential outcomes with early and late repeat transplantation in the era of the lung allocation score. 
  • Diltiazem preserves direct vasodilator response but fails to suppress intimal proliferation in rat allograft coronary artery disease. 
  • Does Anticoagulation Improve Flap Outcomes in Hypercoagulable Patients? A Systematic Review. 
  • Does compliance mismatch alone cause neointimal hyperplasia? 
  • Does recipient age impact functional outcomes of orthotopic heart transplantation? 
  • Donation After Circulatory Death in Heart Transplantation: History, Outcomes, Clinical Challenges, and Opportunities to Expand the Donor Pool. 
  • Donation after cardiac death: the University of Wisconsin experience with liver transplantation. 
  • Donation after cardiac death: the University of Wisconsin experience. 
  • Donation after cardiac death: the university of wisconsin experience with renal transplantation. 
  • Donor and recipient age matching in heart transplantation: analysis of the UNOS Registry. 
  • Donor apoptotic cell-based therapy for effective inhibition of donor-specific memory T and B cells to promote long-term allograft survival in allosensitized recipients. 
  • Donor factors affecting outcome after pancreas transplantation. 
  • Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy. 
  • Donor hepatic function: a factor in postreperfusion syndrome. 
  • Donor immune reconstitution after liver-small bowel transplantation for multiple intestinal atresia with immunodeficiency. 
  • Donor risk index predicts graft failure reliably but not post-transplant infections. 
  • Donor-Recipient Height Mismatch Is Associated With Decreased Survival in Pediatric-to-Adult Liver Transplant Recipients. 
  • Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants. 
  • Donor-reactive T-cell stimulation history and precursor frequency: barriers to tolerance induction. 
  • Dorsal onlay urethroplasty for urethral stricture repair. 
  • Double renal allografts successfully increase utilization of kidneys from older donors within a single organ procurement organization. 
  • Dual Kidney Allocation Score: A Novel Algorithm Utilizing Expanded Donor Criteria for the Allocation of Dual Kidneys in Adults. 
  • Dual Procurement of Lung and Heart Allografts Does Not Negatively Affect Lung Transplant Outcomes. 
  • Dual targeting: Combining costimulation blockade and bortezomib to permit kidney transplantation in sensitized recipients. 
  • Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience. 
  • Early Postoperative Complications following Gracilis Free Muscle Transfer for Facial Reanimation: A Systematic Review and Pooled Data Analysis. 
  • Early Postoperative Emergency Department Care of Abdominal Transplant Recipients. 
  • Early barriers to neonatal porcine islet engraftment in a dual transplant model. 
  • Effect of CXCL-1/KC production in high risk vascularized corneal allografts on T cell recruitment and graft rejection. 
  • Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation. 
  • Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. 
  • Effect of HMG CoA reductase inhibitors on the development of chronic lung allograft dysfunction. 
  • Effect of an anti-C5a monoclonal antibody indicates a prominent role for anaphylatoxin in pulmonary xenograft dysfunction. 
  • Effect of continuous complement inhibition using soluble complement receptor type 1 on survival of pig-to-primate cardiac xenografts. 
  • Effect of donor factors on early graft survival in adult cadaveric renal transplantation. 
  • Effect of irrigation fluids on arterial and venous endothelium after ischemia. 
  • Effect of levodopa priming on dopamine neuron transplant efficacy and induction of abnormal involuntary movements in parkinsonian rats. 
  • Effect of surgical and spontaneous portasystemic shunts on liver transplantation. 
  • Effects of DR mismatch on long-term graft survival in simultaneous kidney-pancreas transplantation. 
  • Effects of Ideal Versus Total Body Weight Dosage of Rabbit Antithymocyte Globulin on Outcomes of Kidney Transplant Patients With High Immunologic Risk. 
  • Effects of combined treatment with CD25- and CD154-specific monoclonal antibodies in non-human primate allotransplantation. 
  • Effects of donor splenocytes treated with mitomycin C on rat hepatic, cardiac, and intestinal allografts. 
  • Effects of immunosuppression and pretransplant splenectomy in newborn cardiac xenograft survival. 
  • Effects of topical and subconjunctival bevacizumab in high-risk corneal transplant survival. 
  • Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. 
  • Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model. 
  • Efficacy of steroids and hyperbaric oxygen on survival of dorsal skin flaps in rats. 
  • Eighth Annual International Umbilical Cord Blood Transplantation Symposium, San Francisco, California, June 3-5, 2010. 
  • Elevated Donor Hemoglobin A1C Impairs Kidney Graft Survival From Deceased Donors With Diabetes Mellitus: A National Analysis. 
  • Elevated HbA1c in donor organs from patients without a diagnosis of diabetes portends worse liver allograft survival. 
  • Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients. 
  • Emerging New Approaches in Desensitization: Targeted Therapies for HLA Sensitization. 
  • Emerging trends in transplantation of inherited metabolic diseases. 
  • Endophthalmitis Rates and Clinical Outcomes Following Penetrating and Endothelial Keratoplasty. 
  • Endoscopic harvesting device type and outcomes in patients undergoing coronary artery bypass surgery. 
  • Endoscopic-Assisted Radial Forearm Free Flap Harvest: A Novel Technique to Reduce Donor Site Morbidity. 
  • Engraftment in 86 with patients lymphoid malignancy after autologous marrow transplantation. 
  • Engraftment of human synovium into severe combined immune deficient mice. Migration of human peripheral blood T cells to engrafted human synovium and to mouse lymph nodes. 
  • Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques. 
  • Enhancing human islet transplantation by localized release of trophic factors from PLG scaffolds. 
  • Ensuring long-term equity after pediatric liver transplantation. 
  • Epithelial clara cell injury occurs in bronchiolitis obliterans syndrome after human lung transplantation. 
  • Eplet mismatch scores and de novo donor-specific antibody development in simultaneous pancreas-kidney transplantation. 
  • Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation. A prospective trial of tacrolimus immunosuppression with percutaneous biopsy. 
  • Establishment of normal ranges of laser Doppler blood flow in autologous tissue transplants. 
  • Ethylenecarbodiimide-fixed donor splenocyte infusions differentially target direct and indirect pathways of allorecognition for induction of transplant tolerance. 
  • Ethylenecarbodiimide-treated splenocytes carrying male CD4 epitopes confer histocompatibility Y chromosome antigen transplant protection by inhibiting CD154 upregulation. 
  • Eudaimonia: An Aristotelian approach to transplantation. 
  • Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial. 
  • Evidence for an immune barrier after in utero hematopoietic-cell transplantation. 
  • Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial. 
  • Examination of the mechanisms responsible for tolerance induction after intrathymic inoculation of allogeneic bone marrow. 
  • Experience with 100 consecutive simultaneous kidney-pancreas transplants with bladder drainage. 
  • Experience with 500 simultaneous pancreas-kidney transplants. 
  • Experience with pancreas retransplantation. 
  • Experimental modeling of desensitization: What have we learned about preventing AMR? 
  • Expression of heme oxygenase-1 can determine cardiac xenograft survival. 
  • Extending the boundaries of acceptable organ donors: a means of expanding the donor pool for liver transplantation. 
  • Extracorporeal membrane oxygenation post lung transplantation. 
  • Extracorporeal membrane oxygenation support and post-heart transplant outcomes among United States adults. 
  • FK 506 induction and rescue therapy in pancreas transplant recipients. 
  • FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors. 
  • Factors associated with short- versus long-term survival after lung transplant. 
  • Factors which have a significant effect on the survival of human skin grafts. 
  • Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor" mobilization of peripheral blood progenitor cells. 
  • Fetal hippocampal grafts containing CA3 cells restore host hippocampal glutamate decarboxylase-positive interneuron numbers in a rat model of temporal lobe epilepsy. 
  • Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics. 
  • Free jejunal interposition graft for reconstruction of the esophagus. 
  • Free vascularized fibular graft reconstruction of large skeletal defects after tumor resection. 
  • Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux. 
  • Gamma-irradiation reduces the allogenicity of donor corneas. 
  • Gene Therapy for Modulation of T-Cell-Mediated Immune Response Provoked by Corneal Transplantation. 
  • Genetic determinants of renal transplant outcome: where do we stand? 
  • Genetic engineering of a suboptimal islet graft with A20 preserves beta cell mass and function. 
  • Genetic regulation of rejection and survival following human lung transplantation by the innate immune receptor CD14. 
  • Going the distance for procurement of donation after circulatory death livers for transplantation-Does reimbursement reflect reality? 
  • Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. 
  • Graft survival in a rhesus renal transplant model after immunotoxin-mediated T-cell depletion is enhanced by mycophenolate and steroids. 
  • Graft-extrinsic cells predominate in vein graft arterialization. 
  • HOPE in action: A prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIV. 
  • Half-life analysis of pancreas and kidney transplants. 
  • Hand transplantation in the United States: experience with 3 patients. 
  • Haploidentical transplantation for leukemia. 
  • Harnessing the B Cell Response in Kidney Transplantation - Current State and Future Directions. 
  • Heart Transplantation Survival and the Use of Traumatically Brain-Injured Donors: UNOS Registry Propensity-Matched Analysis. 
  • Heart Transplantation: An In-Depth Survival Analysis. 
  • Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia. 
  • Hematopoietic stem cells convert into liver cells within days without fusion. 
  • Hemodynamic and metabolic variables predict porcine ex vivo liver function. 
  • Hemorrhagic Herpes Simplex Virus Type 1 Nephritis: An Unusual Cause of Acute Allograft Dysfunction. 
  • Hepatic allograft-derived Kupffer cells regulate T cell response in rats. 
  • High-frequency alloreactive T cells augment effector function of low-frequency CD8+ T-cell responses under CD28/CD154 blockade. 
  • Histocompatibility and liver transplantation. 
  • Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center study. 
  • Host priming, not target antigen type, decides rejection rate in mice primed with MHC II "knockout" cultured keratinocytes. 
  • How does alemtuzumab affect long-term graft and patient outcomes after deceased-donor kidney transplantation? 
  • Human neural stem cell transplants improve motor function in a rat model of Huntington's disease. 
  • Human umbilical cord blood endothelial progenitor cells decrease vein graft neointimal hyperplasia in SCID mice. 
  • Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group. 
  • IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates. 
  • IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses. 
  • IL-7 receptor heterogeneity as a mechanism for repertoire change during postdepletional homeostatic proliferation and its relation to costimulation blockade-resistant rejection. 
  • Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation. 
  • Immunity to MHC class I antigen after direct DNA transfer into skeletal muscle. 
  • Immunologic risks of combined kidney-pancreas transplantation. 
  • Immunoregulation and tolerance. 
  • Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection. 
  • Impact of ABO compatibility on outcomes after heart transplantation in a national cohort during the past decade. 
  • Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study. 
  • Impact of HIV seropositivity on graft and patient survival after cadaveric renal transplantation in the United States in the pre highly active antiretroviral therapy (HAART) era: an historical cohort analysis of the United States Renal Data System. 
  • Impact of Induction Immunosuppression on Post-Transplant Outcomes of Patients Bridged with Contemporary Left Ventricular Assist Devices. 
  • Impact of Leukocyte Function-Associated Antigen-1 Blockade on Endogenous Allospecific T Cells to Multiple Minor Histocompatibility Antigen Mismatched Cardiac Allograft. 
  • Impact of different forms of recipient antigen and different routes of antigen administration in donor pretreatment for preventing graft-versus-host disease in rat small bowel transplantation. 
  • Impact of donor and recipient age difference on long-term allograft survival after living donor renal transplantation: analysis of 478 cases. 
  • Impact of donor factors and preservation on function and survival after liver transplantation. 
  • Impact of graft type on outcome in pediatric liver transplantation: a report From Studies of Pediatric Liver Transplantation (SPLIT). 
  • Impact of improving immunosuppressive treatment on outcome in cadaveric kidney transplantation. 
  • Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. 
  • Improved Outcomes in Severe Primary Graft Dysfunction After Heart Transplantation Following Donation After Circulatory Death Compared With Donation After Brain Death. 
  • Improved microsurgical anastomotic patency with low molecular weight heparin. 
  • Improvement in Liver Transplant Outcomes From Older Donors: A US National Analysis. 
  • In situ and systemic cellular immunity associated with orthotopic rat liver allograft acceptance or rejection. 
  • In utero hematopoietic stem cell transplants prolong survival of postnatal kidney transplantation in monkeys. 
  • In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats. 
  • Incidence and early outcomes associated with pre-transplant antivimentin antibodies in the cardiac transplantation population. 
  • Incidence of Postreperfusion Hyperfibrinolysis in Liver Transplantation by Donor Type and Observed Treatment Strategies. 
  • Incidence of acute cellular rejection following granulocyte colony-stimulating factor administration in lung transplantation: A retrospective case-cohort analysis. 
  • Incidence of cytomegalovirus disease in renal transplantation without antilymphocyte induction: is prophylaxis necessary? 
  • Increased kidney transplantation utilizing expanded criteria deceased organ donors with results comparable to standard criteria donor transplant. 
  • Increased living donor volunteer rates with a formal recipient family education program. 
  • Increased mortality at low-volume orthotopic heart transplantation centers: should current standards change? 
  • Increased survival of skin flaps by scavengers of superoxide radical. 
  • Increasing utilization of human T-cell lymphotropic virus (+) donors in liver transplantation: is it safe? 
  • Indications and donor selections for allogeneic stem cell transplantation in children with hematologic malignancies. 
  • Induction of specific tolerance by intrathymic injection of recipient muscle cells transfected with donor class I major histocompatibility complex. 
  • Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation. 
  • Infected bilomas in liver transplant recipients: clinical features, optimal management, and risk factors for mortality. 
  • Infections after kidney transplantation. Does age matter? 
  • Infectious complications of vascularized composite allograft transplantation. 
  • Infiltrating cell phenotypes and patterns associated with hepatic allograft rejection or acceptance. 
  • Influence of changes in pretransplant sensitization on patient and graft survival in cadaver renal transplantation. 
  • Influence of nucleated cell dose on overall survival of unrelated cord blood transplantation for patients with severe acquired aplastic anemia: a study by eurocord and the aplastic anemia working party of the European group for blood and marrow transplantation. 
  • Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgery. 
  • Influence of pretransplant panel-reactive antibody on outcomes in 8,160 heart transplant recipients in recent era. 
  • Innate Functions of Dendritic Cell Subsets in Cardiac Allograft Tolerance. 
  • Innate immunity influences long-term outcomes after human lung transplant. 
  • Institutional Outcomes of Leech Therapy for Venous Congestion in 87 Patients. 
  • Interleukin-15 receptor blockade in non-human primate kidney transplantation. 
  • Intestinal Perforation in Renal Transplant Recipients: A Single Center Experience of 2123 Recipients. 
  • Intestinal transplantation at the University of Nebraska Medical Center: 1990 to 2001. 
  • Intestinal transplantation. 
  • Intragraft CD11b(+) IDO(+) cells mediate cardiac allograft tolerance by ECDI-fixed donor splenocyte infusions. 
  • Intraoperative angiography using laser-assisted indocyanine green imaging to map perfusion of forehead flaps. 
  • Intrathymic injection of donor alloantigens induces donor-specific vascularized allograft tolerance without immunosuppression. 
  • Intravenous immunoglobulin and plasmapheresis in acute humoral rejection: experience in renal allograft transplantation. 
  • Invited commentary. 
  • Irradiation for xenogeneic transplantation. 
  • Is Functional Independence Associated With Improved Long-Term Survival After Lung Transplantation? 
  • Isolated intestinal transplantation for intestinal failure. 
  • Isolation and transplantation of autologous circulating endothelial cells into denuded vessels and prosthetic grafts: implications for cell-based vascular therapy. 
  • Kidney allograft survival of African American and Caucasian American recipients with lupus. 
  • Kidney transplantation using alemtuzumab, belatacept, and sirolimus: Five-year follow-up. 
  • Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy. 
  • Knee osteotomy and meniscal transplantation: indications, technical considerations, and results. 
  • LFA-1-specific therapy prolongs allograft survival in rhesus macaques. 
  • LMP-420, a small molecular inhibitor of TNF-α, prolongs islet allograft survival by induction of suppressor of cytokine signaling-1: synergistic effect with cyclosporin-A. 
  • Laparoscopic living donor nephrectomy and multiple renal arteries. 
  • Laparoscopic sleeve gastrectomy improves renal transplant candidacy and posttransplant outcomes in morbidly obese patients. 
  • Laparoscopic versus open donor nephrectomy: comparing ureteral complications in the recipients and improving the laparoscopic technique. 
  • Laryngeal transplantation in the setting of cancer: a rat model. 
  • Late graft loss and long-term outcome after isolated intestinal transplantation in children. 
  • Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. 
  • Late withdrawal of cyclosporine in stable renal transplant recipients. 
  • Lesioning of the striatum reverses motor asymmetry in the 6-hydroxydopamine rodent model of parkinsonism. 
  • Less Is More in Post Pediatric Heart Transplant Care. 
  • Leukotrienes in renal transplant rejection in rats. Distinct roles for leukotriene B4 and peptidoleukotrienes in the pathogenesis of allograft injury. 
  • Live donor liver transplantation with older donors: Increased long-term graft loss due to HCV recurrence. 
  • Liver and intestine transplantation in the United States, 1997-2006. 
  • Liver retransplantation: the University of Wisconsin experience. 
  • Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. 
  • Liver transplantation at safety net hospitals: Potentially vulnerable patients with noninferior outcomes. 
  • Liver transplantation at the University of Wisconsin. 
  • Liver transplantation for alcoholic liver disease. 
  • Liver transplantation for biliary atresia: 19-year, single-center experience. 
  • Liver transplantation for liver malignancies in Wilson's disease: two novel cases. 
  • Liver transplantation from controlled non-heart-beating donors. 
  • Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review. 
  • Liver transplantation in pediatric patients: twenty years of experience at the University of Wisconsin. 
  • Living related and unrelated donors for kidney transplantation. A 28-year experience. 
  • Living related donor liver transplantation at the University of Nebraska Medical Center (1996). 
  • Living unrelated renal donation: the University of Wisconsin experience. 
  • Living-related kidney transplant or simultaneous pancreas-kidney for diabetic renal failure? 
  • Living-unrelated renal donor transplantation: the UNOS experience, 1987-1991. United Network for Organ Sharing. 
  • Living-unrelated renal transplantation at the University of Wisconsin. 
  • Living-unrelated renal transplantation at the University of Wisconsin. 
  • Local Burn Injury Promotes Defects in the Epidermal Lipid and Antimicrobial Peptide Barriers in Human Autograft Skin and Burn Margin: Implications for Burn Wound Healing and Graft Survival. 
  • Long term tolerability and clinical outcomes associated with tocilizumab in the treatment of refractory antibody mediated rejection (AMR) in pediatric renal transplant recipients. 
  • Long-term follow-up of T cell-depleted allogeneic bone marrow transplantation in refractory multiple myeloma: importance of allogeneic T cells. 
  • Long-term outcome of early steroid withdrawal after kidney transplantation in African American recipients monitored by surveillance biopsy. 
  • Long-term outcome of simultaneous kidney-pancreas transplantation: analysis of 61 patients with more than 5 years follow-up. 
  • Long-term outcomes and quality of life after intestine transplantation. 
  • Long-term outcomes in simultaneous kidney-pancreas transplant recipients. 
  • Long-term outcomes in simultaneous kidney-pancreas transplantation. 
  • Long-term outcomes in simultaneous pancreas-kidney transplantation: lessons relearned. 
  • Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb. 
  • Long-term outcomes of simultaneous heart and kidney transplantation in pediatric recipients. 
  • Long-term pancreatic function: potential benefits. 
  • Long-term survival and cure after marrow transplantation for congenital hypoplastic anaemia (Diamond-Blackfan syndrome). 
  • Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154. 
  • Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. 
  • Long-term tolerance of islet allografts in nonhuman primates induced by apoptotic donor leukocytes. 
  • Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients. 
  • Low-carbohydrate diets and prostate cancer: how low is "low enough"? 
  • Low-dose chemotherapy for Epstein-Barr virus-positive post-transplantation lymphoproliferative disease in children after solid organ transplantation. 
  • Low-dose total-body irradiation and alemtuzumab-based reduced-intensity conditioning regimen results in durable engraftment and correction of clinical disease among children with chronic granulomatous disease. 
  • Lung Transplant Center Volume Ameliorates Adverse Influence of Prolonged Ischemic Time on Mortality. 
  • Lung Transplantation and the Era of the Sensitized Patient. 
  • Lung transplantation at Duke University Medical Center. 
  • Lung transplantation delays gastric motility in patients without prior gastrointestinal surgery-A single-center experience of 412 consecutive patients. 
  • Lung transplantation using allografts with more than 8 hours of ischemic time: A single-institution experience. 
  • Lymphocyte depletion and risk of acute rejection in renal transplant recipients at increased risk for delayed graft function. 
  • Macrophage migration into hepatic xenografts in the hamster-to-rat combination. 
  • Macroporous Dual-compartment Hydrogels for Minimally Invasive Transplantation of Primary Human Hepatocytes. 
  • Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies. 
  • Management of primary graft failure after heart transplantation: Preoperative risks, perioperative events, and postoperative decisions. 
  • Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation. 
  • Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation. 
  • Marrow transplantation for severe aplastic anemia. Long-term outcome in fifty "untransfused" patients. 
  • Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment? 
  • Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. 
  • Measuring Endothelial Cell Loss on DMEK Grafts After Transplantation in Human Cadaveric Whole Eyes: Description of the Technique and Pilot Study. 
  • Measuring the Impact of Targeting FcRn-Mediated IgG Recycling on Donor-Specific Alloantibodies in a Sensitized NHP Model. 
  • Mechanisms of tolerance induced by PG490-88 in a bone marrow transplantation model. 
  • Mechanisms of tolerance induced by an immunotoxin against CD3 epsilon in a rhesus kidney allograft model. 
  • Mechanisms of tolerance to parental parathyroid tissue when combined with human allogeneic thymus transplantation. 
  • Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease. 
  • Meeting Report of the 13th Congress of the International Society of Vascularized Composite Allotransplantation. 
  • Meeting report of the STAR-Sensitization in Transplantation Assessment of Risk: Naïve Abdominal Transplant Organ subgroup focus on kidney transplantation. 
  • Memory T cells: A helpful guard for allogeneic hematopoietic stem cell transplantation without causing graft-versus-host disease. 
  • Memory T-cell-specific therapeutics in organ transplantation. 
  • Meniscal allograft transplantation. Part 1: systematic review of graft biology, graft shrinkage, graft extrusion, graft sizing, and graft fixation. 
  • Meta-analysis of Timing for Microsurgical Free-Flap Reconstruction for Lower Limb Injury: Evaluation of the Godina Principles. 
  • Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates. 
  • Methyldopa therapy and outcome in cadaveric renal transplantation. 
  • Micro-anastomosis of 0.3-0.4 mm vessels after cold ischemia using a rat model of toe-to-thumb transplantation. 
  • Microvascular Anastomoses Using End-to-End versus End-to-Side Technique in Lower Extremity Free Tissue Transfer. 
  • Midterm results of osteochondral lesions of the talar shoulder treated with fresh osteochondral allograft transplantation. 
  • Mitigating the Impact of Using Female Donor Hearts in Male Recipients Using BMI Difference. 
  • Modified simple limbal epithelial transplantation using cryopreserved amniotic membrane for unilateral limbal stem cell deficiency. 
  • Molecular approaches for the treatment of atherosclerosis. 
  • Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA class I. 
  • Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model. 
  • Morphologic examination of sequential bone marrow biopsies after nonmyeloablative stem cell transplantation complements molecular studies of donor engraftment. 
  • Multicenter evaluation of the bovine mesenteric vein bioprostheses for hemodialysis access in patients with an earlier failed prosthetic graft. 
  • Multivariate analysis of donor-specific versus random transfusion protocols in haploidentical living-related transplants. 
  • Muscle versus Fasciocutaneous Free Flaps in Lower Extremity Traumatic Reconstruction: A Multicenter Outcomes Analysis. 
  • Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients. 
  • Nanoparticle Platforms for Antigen-Specific Immune Tolerance. 
  • National Heart, Lung, and Blood Institute and American Association for Thoracic Surgery Workshop Report: Identifying collaborative clinical research priorities in lung transplantation. 
  • Natural-killer-cell function and bone marrow transplantation. 
  • Need for improvements in simultaneous heart-kidney allocation: The limitation of pretransplant glomerular filtration rate. 
  • Neutralizing BAFF/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model. 
  • New developments in the diagnosis and treatment of infections in lung transplant recipients. 
  • Newborn discordant cardiac xenotransplantation in primates: a model of natural antibody depletion. 
  • Non-anti-Gal alpha1-3Gal antibody mechanisms are sufficient to cause hyperacute lung dysfunction in pulmonary xenotransplantation. 
  • Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates. 
  • Nonmyeloablative regimen preserves "niches" allowing for peripheral expansion of donor T-cells. 
  • Novel Magnetic Resonance Imaging for Assessment of Bronchial Stenosis in Lung Transplant Recipients. 
  • Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial. 
  • OKT3 vs ALG induction therapy in combined pancreas-kidney transplantation. 
  • Obesity as a risk factor following renal transplantation. 
  • Of ends and means. 
  • Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study. 
  • One Size Does Not Fit All--Regional Variation in the Impact of the Share 35 Liver Allocation Policy. 
  • One thousand liver transplants. The lessons learned. 
  • Operational immune tolerance towards transplanted allogeneic pancreatic islets in mice and a non-human primate. 
  • Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients. 
  • Optimizing PLG nanoparticle-peptide delivery platforms for transplantation tolerance using an allogeneic skin transplant model. 
  • Organ-specific patterns of donor antigen-specific hyporeactivity and peripheral blood allogeneic microchimerism in lung, kidney, and liver transplant recipients. 
  • Orthotopic liver transplantation with selective use of venovenous bypass. 
  • Outcome after splenic vein thrombosis in the pancreas allograft. 
  • Outcomes after Unrelated Umbilical Cord Blood Transplantation for Children with Osteopetrosis. 
  • Outcomes among 562 recipients of placental-blood transplants from unrelated donors. 
  • Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation. 
  • Outcomes in bicaval versus biatrial techniques in heart transplantation: an analysis of the UNOS database. 
  • Outcomes in kidney transplant recipients from older living donors. 
  • Outcomes of Liver Transplantation Among Older Recipients With Nonalcoholic Steatohepatitis in a Large Multicenter US Cohort: the Re-Evaluating Age Limits in Transplantation Consortium. 
  • Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation. 
  • Outcomes of liver retransplantation in patients with primary sclerosing cholangitis. 
  • Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. 
  • Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort. 
  • Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy. 
  • PD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue. 
  • PLG scaffold delivered antigen-specific regulatory T cells induce systemic tolerance in autoimmune diabetes. 
  • Paediatric renal transplantation: a single centre study. 
  • Pancreas Transplantation: Indications, Techniques, and Outcomes. 
  • Pancreas transplantation at the University of Maryland. 
  • Pancreas transplantation at the University of Wisconsin. 
  • Pancreas transplantation for patients with diabetes mellitus. American Diabetes Association. 
  • Pancreas transplantation: the Nebraska experience. 
  • Pancreatic islet transplantation using the nonhuman primate (rhesus) model predicts that the portal vein is superior to the celiac artery as the islet infusion site. 
  • Partial splenectomy before a hematopoietic stem cell transplantation in children. 
  • Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution. 
  • Patient demographics and surgical characteristics in ACL revision: a comparison of French, Norwegian, and North American cohorts. 
  • Penetrating keratoplasty in the Singapore National Eye Centre and donor cornea acquisition in the Singapore Eye Bank. 
  • Perineal and lower extremity reconstruction. 
  • Peripheral blood detection of systemic graft-specific xeno-antibodies following transplantation of human neural progenitor cells into the porcine spinal cord. 
  • Permanent survival of fully MHC-mismatched islet allografts by targeting a single chemokine receptor pathway. 
  • Perspective: research highlights at the Duke University center for AIDS research. Immunoreconstitution in HIV infection: the role of the thymus. 
  • Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide. 
  • Phenotype and patterns of inflammatory cell infiltration associated with rejection or acceptance of rat liver allografts. 
  • Piceatannol in combination with low doses of cyclosporine A prolongs kidney allograft survival in a stringent rat transplantation model. 
  • Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study. 
  • Platelet-derived CD154: ultrastructural localization and clinical correlation in organ transplantation. 
  • Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery. 
  • Podocyte density is reduced in kidney allografts with high-risk APOL1 genotypes at transplantation. 
  • Poly(ethylene glycol) hydrogels with cell cleavable groups for autonomous cell delivery. 
  • Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation. 
  • Portable normothermic ex-vivo lung perfusion, ventilation, and functional assessment with the Organ Care System on donor lung use for transplantation from extended-criteria donors (EXPAND): a single-arm, pivotal trial. 
  • Portal venous donor-specific transfusion in conjunction with sirolimus prolongs renal allograft survival in nonhuman primates. 
  • Positive serum cryoglobulin is associated with worse outcome after liver transplantation for chronic hepatitis C. 
  • Post-transplant HLA class II antibodies and high soluble CD30 levels are independently associated with poor kidney graft survival. 
  • Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients. 
  • Postoperative cognitive dysfunction and mortality following lung transplantation. 
  • Posttransplant Outcome of Lean Compared With Obese Nonalcoholic Steatohepatitis in the United States: The Obesity Paradox. 
  • Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment. 
  • Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation. 
  • Pre-transplant analysis of accommodation in donor pigs. 
  • Predictive factors for immunologic graft failure in cadaver renal transplant recipients. 
  • Preemptive donor apoptotic cell infusions induce IFN-γ-producing myeloid-derived suppressor cells for cardiac allograft protection. 
  • Preliminary experience with FK 506 in pancreas transplant recipients. 
  • Preliminary experience with split liver transplantation. 
  • Preoperative anemia predicts thrombosis and free flap failure in microvascular reconstruction. 
  • Preoperative carfilzomib and lulizumab based desensitization prolongs graft survival in a sensitized non-human primate model. 
  • Preoperative estimation in living related donor transplantation: clinical correlation and donor/recipient ratio. 
  • Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients. 
  • Pretransplant status and patient survival following liver transplantation. 
  • Prevention of acute lung injury in swine: depletion of pulmonary intravascular macrophages using liposomal clodronate. 
  • Prevention of autoimmune islet allograft destruction by engraftment of donor T cells. 
  • Primate renal transplants using immunotoxin. 
  • Progenitor cell dose determines the pace and completeness of engraftment in a xenograft model for cord blood transplantation. 
  • Prognostic significance of microvascular thrombosis in donor kidney allograft biopsies. 
  • Prolonged discordant cardiac xenograft survival in newborn recipients. 
  • Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model. 
  • Prolonged function of macrophage, von Willebrand factor-deficient porcine pulmonary xenografts. 
  • Prolonged heart xenograft survival using combined total lymphoid irradiation and cyclosporine. 
  • Prolonged postlesion transplantation delay adversely influences survival of both homotopic and heterotopic fetal hippocampal cell grafts in Kainate-lesioned CA3 region of adult hippocampus. 
  • Prolonged survival of class II transactivator-deficient cardiac allografts. 
  • Prolonged survival of hepatic xenografts in the hamster to rat combination: efficacy of cyclosporine in combination with splenectomy. 
  • Prolonged survival of pig cardiac xenografts in unmodified newborn baboons. 
  • Protein kinase C inhibition abrogates hepatic ischemic preconditioning responses. 
  • Protocol-based nurse coordinator management of ambulatory tacrolimus dosing in de novo renal transplant recipients-A single-center experience with a large African American population. 
  • Psychosocial Predictors of Mortality Following Lung Transplantation. 
  • Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. 
  • Quantifying the risk of incompatible kidney transplantation: a multicenter study. 
  • Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant. 
  • Quantitative graft integration of fetal hippocampal transplants labeled with 5' bromodeoxyuridine into normal adult hippocampus. 
  • Rabbit anti-thymocyte globulin induction therapy does not prolong survival after lung transplantation. 
  • Rabbit antithymocyte globulin induction and sirolimus monotherapy supports prolonged islet allograft function in a nonhuman primate islet transplantation model. 
  • Racial and socioeconomic disparities in pediatric and young adult liver transplant outcomes. 
  • Racial and socioeconomic disparities in pediatric heart transplant outcomes in the era of anti-thymocyte globulin induction. 
  • Rapamycin Interferes With Postdepletion Regulatory T Cell Homeostasis and Enhances DSA Formation Corrected by CTLA4-Ig. 
  • Rapamycin suppression of host-versus-graft and graft-versus-host disease in MHC-mismatched rats. 
  • Real-Time Microscope-Integrated OCT to Improve Visualization in DSAEK for Advanced Bullous Keratopathy. 
  • Reassessing Recipient Mortality Under the New Heart Allocation System: An Updated UNOS Registry Analysis. 
  • Recent advances in immunosuppressive therapy for prevention of renal allograft rejection. 
  • Receptor tyrosine kinase MerTK suppresses an allogenic type I IFN response to promote transplant tolerance. 
  • Recipient Kupffer cell influx into xenografted liver. 
  • Recipient Myd88 Deficiency Promotes Spontaneous Resolution of Kidney Allograft Rejection. 
  • Reconstruction of the lateral ligaments of the ankle using semi-tendinosis graft. 
  • Reconstruction of the lower extremity with vascularized composite tissue: improved tissue survival and specific indications. 
  • Recruitment of marrow-derived endothelial cells to experimental choroidal neovascularization by local expression of vascular endothelial growth factor. 
  • Rejection of the liver transplant. 
  • Rejection of xenogeneic porcine islets in humanized mice is characterized by graft-infiltrating Th17 cells and activated B cells. 
  • Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. 
  • Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation. 
  • Relationship between antithymocyte globulin, T cell phenotypes, and clinical outcomes in pediatric kidney transplantation. 
  • Relationship between provider volume and outcomes for orthotopic liver transplantation. 
  • Renal Outcomes After Simultaneous Liver-Kidney Transplantation: Results from the US Multicenter Simultaneous Liver-Kidney Transplantation Consortium. 
  • Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study. 
  • Renal transplantation at the University of Wisconsin in the cyclosporine era. 
  • Renal transplantation in adults with thrombotic thrombocytopenic purpura/haemolytic-uraemic syndrome. 
  • Renal transplantation in the American black. 
  • Renal transplantation in the cyclosporine era. 
  • Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors. 
  • Reply: Is hepatocyte necrosis a good marker of donor liver viability during machine perfusion? 
  • Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6/6 HLA matched donors. 
  • Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). 
  • Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia. 
  • Results of free vascularized fibular grafting for femoral head osteonecrosis in patients with systemic lupus erythematosus. 
  • Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. 
  • Results of solitary pancreas transplantation with enteric drainage: is there a benefit from monitoring urinary amylase levels? 
  • Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. 
  • Results of the South-Eastern Organ Procurement Foundation strategy for transplanting sensitized patients. 
  • Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival. 
  • Rethinking the ross procedure in adults. 
  • Retransplantation in the diabetic patient with a pancreas allograft. 
  • Retransplantation in the diabetic with a pancreas allograft after previous kidney or pancreas transplant. 
  • Revisiting a single day salvage conditioning following graft failure. 
  • Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with hurler syndrome. 
  • Risk factors for mortality in lung transplant recipients aged ≥65 years: A retrospective cohort study of 5,815 patients in the scientific registry of transplant recipients. 
  • Risk factors for primary dysfunction after liver transplantation--a multivariate analysis. 
  • Risk factors for renal allograft loss in patients with systemic lupus erythematosus. 
  • Risk of tearing the intact anterior cruciate ligament in the contralateral knee and rupturing the anterior cruciate ligament graft during the first 2 years after anterior cruciate ligament reconstruction: a prospective MOON cohort study. 
  • Role of CCR7 in facilitating direct allosensitization and regulatory T-cell function in high-risk corneal transplantation. 
  • Role of T cell recruitment and chemokine-regulated intra-graft T cell motility patterns in corneal allograft rejection. 
  • SRTR center-specific reporting tools: Posttransplant outcomes. 
  • Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study. 
  • Saphenous vein grafts with multiple versus single distal targets in patients undergoing coronary artery bypass surgery: one-year graft failure and five-year outcomes from the Project of Ex-Vivo Vein Graft Engineering via Transfection (PREVENT) IV trial. 
  • Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantation. 
  • Secondary lymphoid tissue and costimulation-blockade resistant rejection: A nonhuman primate renal transplant study. 
  • Selective Targeting of High-Affinity LFA-1 Does Not Augment Costimulation Blockade in a Nonhuman Primate Renal Transplantation Model. 
  • Sensitization and Desensitization in Vascularized Composite Allotransplantation. 
  • Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report. 
  • Shifting Clinical Trial Endpoints in Kidney Transplantation: The Rise of Composite Endpoints and Machine Learning to Refine Prognostication. 
  • Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. 
  • Significant prolongation of hamster liver transplant survival in Lewis rats by total-lymphoid irradiation, cyclosporine, and splenectomy. 
  • Silencing Porcine CMAH and GGTA1 Genes Significantly Reduces Xenogeneic Consumption of Human Platelets by Porcine Livers. 
  • Simultaneous pancreas-kidney transplantation and living related donor renal transplantation in patients with diabetes: is there a difference in survival? 
  • Simultaneous pancreas-kidney transplantation at the University of Wisconsin. 
  • Simultaneous pancreas-kidney transplantation from donation after cardiac death: successful long-term outcomes. 
  • Simultaneous pancreas/kidney transplantation--a comparison of enteric and bladder drainage of exocrine pancreatic secretions. 
  • Single cell transcriptomics of mouse kidney transplants reveals a myeloid cell pathway for transplant rejection. 
  • Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial. 
  • Sirtuin-1 expression and activity is diminished in aged liver grafts. 
  • Solitary pancreas allografts. The role of percutaneous biopsy and standardized histologic grading of rejection. 
  • Solitary pancreas transplantation. Experience with 62 consecutive cases. 
  • Splenectomy and partial splenectomy improve hematopoietic stem cell engraftment in hypersplenic mice. 
  • Splenic Irradiation for the Treatment of Severe Antibody-Mediated Rejection. 
  • Split tolerance induced by immunotoxin in a rhesus kidney allograft model. 
  • Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia. 
  • Staging of Bilateral Lung Transplantation for High-Risk Patients With Interstitial Lung Disease: One Lung at a Time. 
  • State-Level Variation in Waitlist Mortality and Transplant Outcomes Among Patients Listed for Heart Transplantation in the US From 2011 to 2016. 
  • Storage of amputated parts prior to replantation--an experimental study with rabbit ears. 
  • Strategies for tolerance induction in nonhuman primates. 
  • Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen. 
  • Successful conversion from conventional immunosuppression to anti-CD154 monoclonal antibody costimulatory molecule blockade in rhesus renal allograft recipients. 
  • Successful formation of a chimeric human thymus allograft following transplantation of cultured postnatal human thymus. 
  • Supportive care of the marrow transplant recipient: the Seattle Experience. 
  • Sural flap delay procedure: a preliminary report. 
  • Surgical considerations in lung transplantation: transplant operation and early postoperative management. 
  • Surgical repair of urethral strictures. 
  • Surgical technique in transplantation: how much does it matter? 
  • Surrogate markers for late cardiac allograft survival. 
  • Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors. 
  • Survival after Digit Replantation and Revascularization Is Not Affected by the Use of Interpositional Grafts during Arterial Repair. 
  • Survival of adult rat retinal ganglion cells with regrown axons in peripheral nerve grafts: a comparison of graft attachment with suture of fibrin glue. 
  • Survival of allografted pancreatic islets in the subretinal space in rats. 
  • Survival of grafted fetal neural cells in kainic acid lesioned CA3 region of adult hippocampus depends upon cell specificity. 
  • Survival of subretinal pancreatic islet cell allografts and apoptosis in infiltrating lymphocytes in rats. 
  • Sustained release of nerve growth factor from biodegradable polymer microspheres. 
  • Sutureless lamellar keratoplasty: a modified approach for fibrin glue application. 
  • Systemic transforming growth factor-beta1 gene therapy induces Foxp3+ regulatory cells, restores self-tolerance, and facilitates regeneration of beta cell function in overtly diabetic nonobese diabetic mice. 
  • T-Cell recovery in adults and children following umbilical cord blood transplantation. 
  • Tacrolimus and sirolimus: when bad things happen to good drugs. 
  • Tacrolimus dose requirements in African-American and Caucasian kidney transplant recipients on mycophenolate and prednisone. 
  • Tacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia. 
  • Tailored use of belatacept in adolescent kidney transplantation. 
  • Targeting Calcium Release-activated Calcium Channel Is Not Sufficient to Prevent Rejection in Nonhuman Primate Kidney Transplantation. 
  • Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth. 
  • Techniques, Outcomes, and Complications of Preloaded, Trifolded Descemet Membrane Endothelial Keratoplasty Using the DMEK EndoGlide. 
  • Telomere shortening in cultured autografts of patients with burns. 
  • Temporal Changes in the Impact of HLA Mismatching Among Pediatric Kidney Transplant Recipients. 
  • Temporal Trends and Evolving Outcomes After Simultaneous Liver-Kidney Transplantation: Results from the US SLKT Consortium. 
  • Textbook surgical outcome in lung transplantation: Analysis of a US national registry. 
  • Th17 cell inhibition in a costimulation blockade-based regimen for vascularized composite allotransplantation using a nonhuman primate model. 
  • The "banked" TRAM: a method to insure mastectomy skin-flap survival. 
  • The Clinical Role of Intraoperative Core Temperature in Free Tissue Transfer. 
  • The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort Analysis. 
  • The Influence of Topical Vasodilator-Induced Pharmacologic Delay on Cutaneous Flap Viability and Vascular Remodeling. 
  • The Knife's Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism but With a Significant Risk of CMV Reactivation and Disease in Rhesus Macaques. 
  • The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome. 
  • The STS AVR+CABG composite score: a report of the STS Quality Measurement Task Force. 
  • The VB-1 catheter: an improved catheter for difficult-to-engage internal mammary artery grafts. 
  • The Virtual Crossmatch: An Essential Tool for Transplanting Sensitized Patients. 
  • The Volume-outcome Relationship in Deceased Donor Kidney Transplantation and Implications for Regionalization. 
  • The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success. 
  • The association of enhancement of renal allograft survival by donor-specific blood transfusion with host MHC-linked inhibition of IgG anti-donor class I alloantibody responses. 
  • The association with organ procurement techniques and early cardiac transplant outcomes using cardiac MRI. 
  • The center volume-outcome effect in pancreas transplantation: a national analysis. 
  • The combination of donor and recipient age is critical in determining host immunoresponsiveness and renal transplant outcome. 
  • The effect of 15-deoxyspergualin on hamster-to-rat cardiac xenograft survival. 
  • The effect of TLI and cyclosporine on xenograft survival. 
  • The effect of cyclosporine, total lymphoid irradiation, and cobra venom factor on hyperacute rejection. 
  • The effect of donor age, recipient age, and HLA match on immunologic graft survival in cadaver renal transplant recipients. 
  • The effect of pretreatment with class I major histocompatibility complex (MHC) antigens on hepatic or cardiac allograft survival in the rat. 
  • The effect of soluble complement receptor type 1 on hyperacute allograft rejection. 
  • The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. 
  • The effect of the Statewide Sharing variance on geographic disparity in kidney transplantation in the United States. 
  • The heart transplant allocation change attenuates but does not eliminate blood group O waitlist outcome disadvantage. 
  • The histology of graft adhesion in descemet stripping with endothelial keratoplasty. 
  • The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C. 
  • The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis. 
  • The impact of hypoalbuminemia in kidney-pancreas transplant recipients. 
  • The impact of post-transplant diabetes mellitus on liver transplant outcomes. 
  • The impact of slow graft function on graft outcome is comparable to delayed graft function in deceased donor kidney transplantation. 
  • The influence of RS-61443 on antibody-mediated rejection. 
  • The influence of dose and dose rate of total lymphoid irradiation in the rat cardiac allograft model. 
  • The influence of institutional volume on the incidence of complications and their effect on mortality after heart transplantation. 
  • The influence of pretransplant transfusions, using different blood products, on patient sensitization and renal allograft survival. 
  • The platysma myocutaneous flap. Indications and caveats. 
  • The potential of xenotransplants. 
  • The problem of transplanting the sensitized patient: whose problem is it? 
  • The relationship of transfusion and presensitization with graft and patient survival. 
  • The role of RT1.a major histocompatibility antigens in prolonging the survival of hepatic allografts in the rat. 
  • The role of alemtuzumab in facilitating maintenance immunosuppression minimization following solid organ transplantation. 
  • The role of class I antigens in hyperacute rejection of hepatic allografts in rats. 
  • The role of class I major histocompatibility complex antigens in prolonging the survival of hepatic allografts in the rat. 
  • The role of pre-ischaemic application of the nitric oxide donor spermine/nitric oxide complex in enhancing flap survival in a rat model. 
  • The role of therapeutic apheresis in high immunologic risk renal transplantation: a review of current trends. 
  • The significance of pre-operative coronary interventions on outcome after pancreas transplantation. 
  • The use of UW solution in clinical transplantation. A 4-year experience. 
  • The use of local allograft irradiation following renal transplantation. 
  • The use of umbilical cord blood in mismatched related and unrelated hemopoietic stem cell transplantation. 
  • The vascularization of free flaps: a clinical and experimental correlation. 
  • The vascularized fibular graft in precollapse osteonecrosis: is long-term hip preservation possible? 
  • Thoracic organ transplantation at Papworth Hospital. 
  • Thrombospondin-1 derived from APCs regulates their capacity for allosensitization. 
  • Thyroid ala cartilage graft laryngotracheoplasty for closure of large pediatric tracheocutaneous fistula. 
  • Thyroid hormone in the treatment of post-transplant acute tubular necrosis (ATN). 
  • Topical ganciclovir treatment in patients with cytomegalovirus endotheliitis receiving penetrating keratoplasty. 
  • Total colony-forming units are a strong, independent predictor of neutrophil and platelet engraftment after unrelated umbilical cord blood transplantation: a single-center analysis of 435 cord blood transplants. 
  • Total lymphoid irradiation and cyclosporine prolongs cardiac allograft survival in the sensitized rat model. 
  • Total lymphoid irradiation for cardiac xenotransplantation in nonhuman primates. 
  • Transcutaneous PO2 monitoring for assessing viability and predicting survival of skin flaps: experimental and clinical correlations. 
  • Transient B-cell depletion combined with apoptotic donor splenocytes induces xeno-specific T- and B-cell tolerance to islet xenografts. 
  • Transplantation for polycystic kidney disease. 
  • Transplantation in miniature swine. 
  • Transplantation in miniature swine. III: effects of MSLA and A-O blood group matching on skin allograft survival. 
  • Transplantation in miniature swine. VI. Factors influencing survival of renal allografts. 
  • Transplantation of enriched and purged peripheral blood progenitor cells from a single apheresis product in patients with non-Hodgkin's lymphoma. 
  • Transplantation of feline islets of Langerhans in the subretinal space of cat eyes. 
  • Transplantation of full-thickness retina in the rhodopsin transgenic pig. 
  • Transplantation of high panel-reactive antibody left ventricular assist device patients without crossmatch using on-bypass pheresis and alemtuzumab. 
  • Transplantation of insulinoma into the diabetic Syrian hamster. 
  • Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. 
  • Transplanting thoracic COVID-19 positive donors: An institutional protocol and report of the first 14 cases. 
  • Treatment of marrow graft recipients with thymopentin. 
  • Treatment of osteonecrosis in the hip of pediatric patients by free vascularized fibular graft. 
  • Treatment with the humanized CD154-specific monoclonal antibody, hu5C8, prevents acute rejection of primary skin allografts in nonhuman primates. 
  • Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium wilfordii Hook F. 
  • Two hundred consecutive simultaneous pancreas-kidney transplants with bladder drainage. 
  • Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment. 
  • Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. 
  • Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT). 
  • Unaltered graft survival and intragraft lymphocytes infiltration in the cardiac allograft of Cxcr3-/- mouse recipients. 
  • Underutilization of pancreas donors. 
  • Unique aspects of rejection and tolerance in liver transplantation. 
  • Unrelated donor marrow transplantation in children. 
  • Unrelated umbilical cord blood transplantation in adult patients. 
  • Updated Results of Rituximab Pre- and Post-BEAM with or without 90Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma. 
  • Urethroplasty with abdominal skin grafts for long segment urethral strictures. 
  • Urological complications and enteric conversion after pancreas transplantation with bladder drainage. 
  • Use of allograft biopsies to assess thymopoiesis after thymus transplantation. 
  • Use of donor serum to prevent passive transfer of hyperacute rejection. 
  • Use of the anterolateral thigh free flap for upper-extremity reconstruction. 
  • Use of tissue blood flow and high energy phosphate content to predict small bowel graft survival. 
  • Using donor exchange paradigms with desensitization to enhance transplant rates among highly sensitized patients. 
  • Utility of telomerase-pot1 fusion protein in vascular tissue engineering. 
  • Utilization of pediatric donors for pancreas transplantation. 
  • Utilization of the older donor for renal transplantation. 
  • Variable allograft responses to pretreatment with donor splenocytes treated with mitomycin C in the rat. 
  • Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. 
  • Vascular Calcification Markers and Hemodialysis Vascular Access Complications. 
  • Vascular Complications after Renal Transplantation: Another Brick in the Wall. 
  • Vascular considerations in foot and ankle free tissue transfer: Analysis of 231 free flaps. 
  • Vascularized Composite Allotransplantation: A Functional Hind Limb Model in Mice. 
  • Vascularized composite allotransplantation at a crossroad. 
  • Vascularized composite allotransplantation in the United States: A descriptive analysis of the Organ Procurement and Transplantation Network Data. 
  • Vascularized composite allotransplants as a mechanistic model for allograft rejection - an experimental study. 
  • Vascularized fibular grafts for avascular necrosis after slipped capital femoral epiphysis: is hip preservation possible? 
  • Vein graft anastomoses with magnets. 
  • Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients. 
  • WNT3A promotes myogenesis of human embryonic stem cells and enhances in vivo engraftment. 
  • What Is Hot and New in Basic and Translational Science in Liver Transplantation in 2022? Report of the Basic and Translational Research Committee of the International Liver Transplantation Society. 
  • Why Do Osteochondral Allografts Survive? Comparative Analysis of Cartilage Biochemical Properties Unveils a Molecular Basis for Durability. 
  • Why do secondary cadaver renal transplants succeed? Results of the South-Eastern Organ Procurement Foundation prospective study, 1977-1982. 
  • Xenograft survival in two species combinations using total-lymphoid irradiation and cyclosporine. 
  • Xenotransplantation-the current status and prospects. 
  • β-Arrestin2 mediates progression of murine primary myelofibrosis. 
• 

  Keywords of People

  • Alexander, John Hunter Peel, Professor of Medicine, Medicine, Cardiology
  • Buckley, Rebecca Hatcher, James Buren Sidbury Distinguished Professor Emeritus of Pediatrics, in the School of Medicine, Pediatrics, Allergy and Immunology
  • Chen, Jun, Professor of Medicine, Duke Cancer Institute
  • Gunn, Michael Dee, Professor of Medicine, Integrative Immunobiology
  • McLendon, Roger Edwin, Professor of Pathology, Pathology
  • Milano, Carmelo Alessio, Joseph W. and Dorothy W. Beard Distinguished Professor of Experimental Surgery, Surgery, Cardiovascular and Thoracic Surgery
  • Stinnett, Sandra Sue, Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics